To investigate the feasibility and potential benefits of non-invasive ventilation (NIV) as a primary strategy for managing acute respiratory failure (ARF) in patients with Madelung's disease, a condition that complicates airway management.
Key Findings:
Both patients were successfully managed with NIV using a total face mask, avoiding endotracheal intubation, which is critical given the high risk of airway complications.
One patient developed bilateral pneumothoraxes as a complication of NIV, which was managed conservatively, underscoring the need for careful monitoring.
Severe obstructive sleep apnea was identified in the second patient, impacting successful weaning and highlighting the importance of screening for OSA.
Interpretation:
A proactive NIV-first approach is a viable and potentially life-saving strategy in patients with Madelung's disease experiencing ARF, suggesting a need for further research in this area.
Limitations:
Limited published data on the management of Madelung's disease during ARF, particularly regarding NIV efficacy.
Scarcity of evidence regarding the association between Madelung's disease and COVID-19-related respiratory failure, which complicates treatment decisions.
Conclusion:
The case series provides valuable insights and a structured management framework for clinicians dealing with ARF in patients with Madelung's disease, emphasizing the need for tailored approaches in this unique patient population.
